<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor="#ffffff">


<P align="center">
<B><FONT face="serif">SECURITIES AND EXCHANGE COMMISSION </FONT></B><BR>
<B><FONT size=2 face="serif">Washington, D.C. 20549</FONT></B><FONT size=2 face="serif"> </FONT><BR>
<BR>
<B><FONT size=5 face="serif">FORM S-8</FONT></B><FONT size=5 face="serif"> </FONT><BR>
<B><FONT size=2 face="serif">Registration Statement</FONT></B><FONT size=2 face="serif"> </FONT><BR>
<B><FONT size=2 face="serif">Under</FONT></B><FONT size=2 face="serif"> </FONT><BR>
<B><FONT size=2 face="serif">The Securities Act of 1933, as amended.</FONT></B><FONT size=2 face="serif"> </FONT><BR>
<BR>
<B><FONT size=5 face="serif">VISUALMED CLINICAL SOLUTIONS CORP.</FONT></B></P>
<P align="center">
<FONT size=2 face="serif">(Exact name of registrant as specified in charter.)</FONT></P>
<TABLE border=0 width=100% cellspacing=0 cellpadding=0>
<TR>
     <TD width=50%></TD>
     <TD width=2%></TD>
     <TD width=47%></TD></TR>
<TR valign="bottom">
	<TD align=center nowrap>
<B><FONT size=2 face="serif">Nevada</FONT></B>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=center nowrap>
<B><FONT size=2 face="serif">88-0436055</FONT></B>
	</TD>
</TR>
<TR valign="bottom">
	<TD align=center nowrap>
<FONT size=2 face="serif">(State or other jurisdiction or organization)</FONT>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=center nowrap>
<FONT size=2 face="serif">(I.R.S. Employer Identification Number)</FONT>
	</TD>
</TR>
</TABLE><BR>
<P align="center">
<B><FONT size=2 face="serif">VISUALMED CLINICAL SOLUTIONS CORP. </FONT></B><BR>
<B><FONT size=2 face="serif">1035 Laurier W. Suite 200 </FONT></B><BR>
<B><FONT size=2 face="serif">Montreal, Quebec </FONT></B><BR>
<B><FONT size=2 face="serif">Canada H2V 2L1 </FONT></B><BR>
<B><FONT size=2 face="serif">(514) 274-1115 </FONT></B><BR>
<FONT size=2 face="serif">(Address and telephone of executive offices, including zip code.) </FONT><BR>
<BR>
<B><FONT size=2 face="serif">THE VISUALMED CLINICAL SOLUTIONS CORP. </FONT></B><BR>
<B><FONT size=2 face="serif">NOVEMBER 2007 NONQUALIFIED STOCK OPTION PLAN</FONT></B></P>
<P align="center">
<B><FONT size=2 face="serif">Gerard Dab, Chairman &amp; CEO </FONT></B><BR>
<B><FONT size=2 face="serif">VISUALMED CLINICAL SOLUTIONS CORP.</FONT></B><BR>
<B><FONT size=2 face="serif">1035 Laurier W. Suite 200 </FONT></B><BR>
<B><FONT size=2 face="serif">Montreal, Quebec </FONT></B><BR>
<B><FONT size=2 face="serif">Canada H2V 2L1 </FONT></B><BR>
<B><FONT size=2 face="serif">(514) 274-1115 </FONT></B><BR>
<FONT size=2 face="serif">(Name, address and telephone of agent for service) </FONT></P>
<P align="left">
<FONT size=2 face="serif">Copies of all communications, including all communications sent to the agent for service, should be sent to:</FONT></P>
<P align="center">
<B><FONT size=2 face="serif">Lombardo Dufresne LLP</FONT></B><BR>
<B><FONT size=2 face="serif">350 Theodore Fremd Ave.</FONT></B><BR>
<B><FONT size=2 face="serif">Rye, NY 10580 </FONT></B><BR>
<B><FONT size=2 face="serif">Tel. (914) 612 7016 </FONT></B><BR>
<B><FONT size=2 face="serif">Fax (914) 612 7038 </FONT></B></P>

<HR noshade align="center" width="100%" size=4>



<p style='page-break-before:always'></p><PAGE>
<TABLE width=100% border=0 cellpadding=0 cellspacing=0>
<TR>
     <TD width="42%"></TD>
     <TD width="2%"></TD>
     <TD width="10%"></TD>
     <TD width="3%"></TD>
     <TD width="5%"></TD>
     <TD width="4%"></TD>
     <TD width="6%"></TD>
     <TD width="1%"></TD>
     <TD width="5%"></TD>
     <TD width="6%"></TD>
     <TD width="8%"></TD>
     <TD width="2%"></TD>
     <TD width="6%"></TD></TR>
<TR valign="bottom">
	<TD align=center colspan=13>
<B><FONT size=2 face="serif">CALCULATION OF REGISTRATION FEE</FONT></B>
	</TD>
</TR>
<TR>
	<TD colspan=13>&nbsp;

	</TD>
</TR>
<TR valign="bottom">
	<TD align=left nowrap>&nbsp;

	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>&nbsp;

	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>

	  <div align="center"></div></TD>
	<TD align=left nowrap>

	  <div align="center"></div></TD>
	<TD align=left nowrap>

	  <div align="center"></div></TD>
	<TD>
	  <div align="center"></div></TD>
	<TD colspan="2" align=left nowrap>
      <div align="center"><B><FONT size=1 face="serif">Proposed</FONT></B>
	    </div></TD>
	<TD>
	  <div align="center"></div></TD>
	<TD align=left nowrap>

	  <div align="center"></div></TD>
	<TD align=left nowrap>

	  <div align="center"></div></TD>
</TR>
<TR valign="bottom">
	<TD align=center nowrap>
<B><FONT size=1 face="serif">Title of Each Class of</FONT></B>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>&nbsp;

	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap colspan=3>
      <div align="center"><B><FONT size=1 face="serif">Aggregate Proposed</FONT></B>
	    </div></TD>
	<TD>
	  <div align="center"></div></TD>
	<TD colspan="2" align=left nowrap>
      <div align="center"><B><FONT size=1 face="serif">Maximum</FONT></B>
	    </div></TD>
	<TD>
	  <div align="center"></div></TD>
	<TD colspan="2" align=left nowrap>
      <div align="center"><B><FONT size=1 face="serif">Amount of</FONT></B>
	    </div></TD>
  </TR>
<TR valign="bottom">
	<TD align=center nowrap>
<B><FONT size=1 face="serif">Securities to be</FONT></B>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=center nowrap>
<B><FONT size=1 face="serif">Amount to be</FONT></B>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap colspan=3>
      <div align="center"><B><FONT size=1 face="serif">Maximum Offering</FONT></B>
	    </div></TD>
	<TD>
	  <div align="center"></div></TD>
	<TD colspan="2" align=left nowrap>
      <div align="center"><B><FONT size=1 face="serif">Aggregate Offering</FONT></B>
	    </div></TD>
	<TD>
	  <div align="center"></div></TD>
	<TD colspan="2" align=left nowrap>
      <div align="center"><B><FONT size=1 face="serif">Registration</FONT></B>
	    </div></TD>
  </TR>
<TR valign="bottom">
	<TD align=center nowrap>
<B><FONT size=1 face="serif">Registered</FONT></B>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=center nowrap>
<B><FONT size=1 face="serif">Registered</FONT></B>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap colspan=3>
      <div align="center"><B><FONT size=1 face="serif">Price per Unit/Share</FONT></B>
	    </div></TD>
	<TD>
	  <div align="center"></div></TD>
	<TD colspan="2" align=left nowrap>
      <div align="center"><B><FONT size=1 face="serif">Price [1]</FONT></B>
	    </div></TD>
	<TD>
	  <div align="center"></div></TD>
	<TD colspan="2" align=left nowrap>
      <div align="center"><B><FONT size=1 face="serif">Fee</FONT></B>
	    </div></TD>
  </TR>
<TR>
	<TD colspan=13>&nbsp;

	</TD>
</TR>
<TR valign="bottom">
	<TD align=left nowrap>
<FONT size=2 face="serif">Common Shares, &#36;0.00001 par value,</FONT>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>&nbsp;

	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>&nbsp;

	</TD>
	<TD align=left nowrap>&nbsp;

	</TD>
	<TD align=left nowrap>&nbsp;

	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>&nbsp;

	</TD>
	<TD align=left nowrap>&nbsp;

	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>&nbsp;

	</TD>
	<TD align=left nowrap>&nbsp;

	</TD>
</TR>
<TR valign="bottom">
	<TD align=left nowrap>
<FONT size=2 face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;issuable upon exercise of stock options</FONT>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>&nbsp;

	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>&nbsp;

	</TD>
	<TD align=left nowrap>&nbsp;

	</TD>
	<TD align=left nowrap>&nbsp;

	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>&nbsp;

	</TD>
	<TD align=left nowrap>&nbsp;

	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>&nbsp;

	</TD>
	<TD align=left nowrap>&nbsp;

	</TD>
</TR>
<TR valign="bottom">
	<TD align=left nowrap>
<FONT size=2 face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;by Grantees</FONT>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=right nowrap>
<FONT size=2 face="serif">1,900,000</FONT>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>
      <div align="right"><FONT size=2 face="serif">&#36;</FONT>
	    </div></TD>
	<TD align=right nowrap>
<FONT size=2 face="serif">0.30</FONT>
	</TD>
	<TD align=left nowrap>
<FONT size=2 face="serif">&nbsp;[1]</FONT>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>
      <div align="right"><FONT size=2 face="serif">&#36;</FONT>
	    </div></TD>
	<TD align=right nowrap>
<FONT size=2 face="serif">570,000</FONT>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>
      <div align="right"><FONT size=2 face="serif">&#36;</FONT>
	    </div></TD>
	<TD align=right nowrap>
<FONT size=2 face="serif">57.34</FONT>
	</TD>
</TR>
<TR>
	<TD colspan=13>&nbsp;

	</TD>
</TR>
<TR valign="bottom">
	<TD align=left nowrap>
<FONT size=2 face="serif">Totals</FONT>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=right nowrap>
<FONT size=2 face="serif">1,900,000</FONT>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>
      <div align="right"><FONT size=2 face="serif">&#36;</FONT>
	    </div></TD>
	<TD align=right nowrap>
<FONT size=2 face="serif">0.30</FONT>
	</TD>
	<TD align=left nowrap>&nbsp;

	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>
      <div align="right"><FONT size=2 face="serif">&#36;</FONT>
	    </div></TD>
	<TD align=right nowrap>
<FONT size=2 face="serif">570,000</FONT>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>
      <div align="right"><FONT size=2 face="serif">&#36;</FONT>
	    </div></TD>
	<TD align=right nowrap>
<FONT size=2 face="serif">57.34</FONT>
	</TD>
</TR>
</TABLE>
<blockquote>
  <p align="left">
    <FONT size=2 face="serif">[1] Estimated solely for the purpose of calculating the registration fee pursuant to paragraphs (c) and (h) of Rule 457 under the Securities Act, as amended, based upon the average of the closing bid and ask prices for
    common shares, as quoted by the OTC Bulletin Board on November 13, 2007. </FONT></p>
</blockquote>
<P align="left">
<FONT size=2 face="serif">In addition, pursuant to rule 416(c) under the Securities Act of 1933 (the &#147;Act&#148;), this registration statement also covers an indeterminate amount of interests to be offered or sold pursuant to the employee
benefit plan described herein. </FONT></P>
<P align="left">
<B><FONT size=2 face="serif">PART I. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS. </FONT></B><FONT size=2 face="serif"> </FONT></P>
<P align="left">
<B><FONT size=2 face="serif">ITEM 1. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;PLAN INFORMATION</FONT></B><BR>
<BR>
<FONT size=2 face="serif">See Item 2 below.</FONT></P>
<P align="left">
<B><FONT size=2 face="serif">ITEM 2. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;REGISTRANT INFORMATION AND EMPLOYEE PLAN ANNUAL INFORMATION. </FONT></B><FONT size=2 face="serif"> </FONT></P>
<P align="left">
<FONT size=2 face="serif">The document containing the information specified in Part I of this registration statement on Form S-8 will be sent or given to participants in the Plan as specified by Rule 428(b)(1) under the Act, as amended. Such
documents are not required to be, and are not being, filed by the Registrant with the Securities and Exchange Commission, either as part of this registration statement or as prospectuses or prospectus supplements pursuant to Rule 424 under the Act,
as amended. Such documents, together with the documents incorporated by reference herein pursuant to Item 3 of Part II of this registration statement on Form S-8, constitute a prospectus that meets the requirements of Section 10(a) of the Act, as
amended.</FONT></P>
<P align="left">
<FONT size=2 face="serif">The documents incorporated by reference in Item 3 of Part II of this registration statement are incorporated by reference in the Section 10(a) prospectus, and are available without charge, upon written or oral request to
VisualMED Clinical Solutions Corp., 1035 Laurier W., Suite 200, Montreal, Quebec Canada, H2V 2L1, (514) 274-1115, Attention: Corporate Secretary.</FONT></P>
<P align="left">
<B><FONT size=2 face="serif">PART II. &nbsp;&nbsp;&nbsp;INFORMATION REQUIRED
IN THE REGISTRATION STATEMENT. </FONT></B><FONT size=2 face="serif"> </FONT></P>

<P align="left">
<B><FONT size=2 face="serif">ITEM
3. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;INCORPORATION OF DOCUMENTS BY REFERENCE. </FONT></B><FONT size=2 face="serif"> </FONT></P>
<P align="left">
<FONT size=2 face="serif">The Registrant hereby incorporates by reference into this Registration Statement the documents listed below. In addition, all documents subsequently filed pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities
Exchange Act of 1934 (the "Exchange Act"), prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by
reference into this Registration Statement and to be a part hereof from the date of filing of such documents: </FONT></P>
<blockquote>
  <p align="left">
    <FONT size=2 face="serif">(a) The Registrant&#146;s Annual Report on Form 10-KSB
    for the fiscal year ended June 30, 2007; and <br>
<br>
(b) All other reports filed pursuant
    to section 13(a) or 15(d) of the Securities Exchange Act of 1934, since the
    end of the fiscal year covered by the Registrant&#146;s document referred to
    in (a) above.</FONT></p>
</blockquote>
<P align="left">
<B><FONT size=2 face="serif">ITEM 4. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;DESCRIPTION OF SECURITIES.</FONT></B></P>

<HR noshade align="center" width="100%" size=4>



<p style='page-break-before:always'></p><PAGE>
<P align="left">
<B><FONT size=2 face="serif">Common Stock</FONT></B></P>
<P align="left">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Our authorized capital stock consists of 100,000,000 shares of common stock, &#36;0.00001 par value per share. The holders of our common stock:</FONT></P>
<UL>
<LI><p align=left>
<FONT size=2 face="serif">have equal ratable rights to dividends from funds legally available if and when declared by our</FONT> <FONT size=2 face="serif">board of directors;</FONT></p></LI>
<LI><p align=left>
<FONT size=2 face="serif">are entitled to share ratably in all of our assets available for distribution to holders of common</FONT> <FONT size=2 face="serif">stock upon liquidation, dissolution or winding up of our affairs;</FONT></p></LI>
<LI><p align=left>
<FONT size=2 face="serif">do not have preemptive, subscription or conversion rights and there are no redemption or sinking</FONT> <FONT size=2 face="serif">fund provisions or rights; and</FONT></p></LI>
<LI><p align=left>
<FONT size=2 face="serif">are entitled to one non-cumulative vote per share on all matters on which stockholders may vote.</FONT></p></LI>
</UL>
<P align="left">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">As of November 13, 2007, we had 55,498,345 shares of common stock outstanding.</FONT></P>
<P align="left">
<B><FONT size=2 face="serif">Non-cumulative voting</FONT></B></P>
<P align="left">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Holders of shares of our common stock do not have cumulative voting rights, which means that the holders of more than 50% of the outstanding shares, voting for the election of directors, can
elect all of the directors to be elected, if they so choose, and, in that event, the holders of the remaining shares will not be able to elect any of our directors. </FONT></P>
<P align="left">
<B><FONT size=2 face="serif">Cash dividends</FONT></B></P>
<P align="left">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">We have not declared any cash dividends in the last two fiscal years. We intend to retain future earnings for use in our business and do not anticipate declaring or paying any cash or stock
dividends on shares of our common shares in the near future. In addition, any determination to declare and pay dividends will be made by our Board of Directors in light of our earnings, financial position, capital requirements and other factors that
our Board of Directors deems relevant. </FONT></P>
<P align="left">
<B><FONT size=2 face="serif">Warrants</FONT></B></P>
<P align="left">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">As of November 19, 2007, there are 10,000,000 warrants outstanding to purchase common stock at an exercise price of &#36;0.01 per share. The warrants are immediately exercisable and these
warrants are exercisable for a period of five years after the date of issuance, March 30, 2007, after which they will expire if not exercised. </FONT></P>
<P align="left">
<B><FONT size=2 face="serif">Anti-takeover provisions</FONT></B></P>
<P align="left">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">There are no Nevada anti-takeover provisions that may have the effect of delaying or preventing a change in control. </FONT></P>
<P align="left">
<B><FONT size=2 face="serif">Stock transfer agent</FONT></B></P>
<P align="left">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Our stock transfer agent for our securities is Olde Monmouth Stock Transfer Co., Inc., 200 Memorial Parkway, Atlantic Highlands, NJ 07716 and its telephone number is (732) 872-2727. </FONT></P>
<P align="left">
<B><FONT size=2 face="serif">ITEM 5. INTEREST OF NAMED EXPERTS AND COUNSEL.</FONT></B><FONT size=2 face="serif"> </FONT></P>
<P align="left">
<FONT size=2 face="serif">Not Applicable.</FONT></P>
<P align="left">
<B><FONT size=2 face="serif">ITEM 6. INDEMNIFICATION OF DIRECTORS AND OFFICERS.</FONT></B><FONT size=2 face="serif"> </FONT></P>
<P align="left">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Under our articles of incorporation and bylaws, we may indemnify an officer or director who is made a party to any proceeding, including a lawsuit, because of his position, if he acted in good
faith and in a manner he reasonably believed to be in our best interest. We may advance expenses incurred in defending a proceeding. To the extent that the officer or director is successful on the merits in a proceeding as to which he is to be
indemnified, we must indemnify him against all expenses incurred, including attorney&#146;s fees. With respect to a derivative action, indemnity may be made only for expenses actually and reasonably incurred in defending the proceeding, and if the
</FONT></P>

<HR noshade align="center" width="100%" size=4>



<p style='page-break-before:always'></p><PAGE>
<P align="left">
<FONT size=2 face="serif">officer or director is judged liable, only by a court order. The indemnification is intended to be to the fullest extent permitted by the laws of the State of Nevada.</FONT></P>
<P align="left">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Insofar as indemnification for liabilities arising under the Act may be permitted to directors, officers and controlling persons of the small business issuer pursuant to the foregoing
provisions, or otherwise, the small business issuer has been advised that in the opinion of the Securities Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. </FONT></P>
<P align="left">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Regarding indemnification for liabilities arising under the Act, which may be permitted to directors or officers under Nevada law, we are informed that, in the opinion of the Securities and
Exchange Commission, indemnification is against public policy, as expressed in the Act and is, therefore, unenforceable.</FONT></P>
<P align="left">
<B><FONT size=2 face="serif">ITEM 7. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;EXEMPTION FROM REGISTRATION.</FONT></B></P>
<P align="left">
<FONT size=2 face="serif">Not Applicable.</FONT><BR>
<BR>
<B><FONT size=2 face="serif">ITEM 8. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;EXHIBITS.</FONT></B></P>
<TABLE border=0 width=100% cellspacing=0 cellpadding=0>
<TR>
     <TD width=13%></TD>
     <TD width=2%></TD>
     <TD width=84%></TD></TR>
<TR valign="bottom">
	<TD align=left nowrap>
<FONT size=2 face="serif">Exhibit 4.1</FONT>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>
<FONT size=2 face="serif">VisualMED Clinical Solutions Corp. November 2007 Nonqualified Stock Option Plan</FONT>
	</TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
	<TD align=left nowrap>
<FONT size=2 face="serif">Exhibit 4.2</FONT>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>
<FONT size=2 face="serif">Form of Non-Qualified Stock Option Agreement</FONT>
	</TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
	<TD align=left nowrap>
<FONT size=2 face="serif">Exhibit 5.1</FONT>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>
<FONT size=2 face="serif">Opinion of Lombardo Dufresne LLP., Attorneys at Law</FONT>
	</TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
	<TD align=left nowrap>
<FONT size=2 face="serif">Exhibit 23.1</FONT>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>
<FONT size=2 face="serif">Consent of Lombardo Dufresne LLP, (included in Exhibit 5.1)</FONT>
	</TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
	<TD align=left nowrap>
<FONT size=2 face="serif">Exhibit 23.2</FONT>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>
<FONT size=2 face="serif">Consent of Manning Elliott LLP, Independent Registered Public Accounting Firm</FONT>
	</TD>
</TR>
</TABLE>
<BR>
<P align="left">
<B><FONT size=2 face="serif">ITEM 9. UNDERTAKINGS.</FONT></B><FONT size=2 face="serif"> </FONT><BR>
<BR>
<FONT size=2 face="serif">The undersigned registrant hereby undertakes:</FONT></P>
<P align="left">
<FONT size=2 face="serif">1. To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement; 2. To include any material information with respect to the plan of distribution not
previously disclosed in the registration statement or any material change to such information in the registration statement; </FONT></P>
<P align="left">
<FONT size=2 face="serif">3. That, for the purpose of determining any liability under the Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial bona fide offering thereof; and 4. To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the
offering.</FONT></P>
<P align="left">
<FONT size=2 face="serif">The undersigned registrant hereby undertakes that, for the purposes of determining any liability under the Act, each filing of the Registrant&#146;s annual report pursuant to Section 13(a) or Section 15(d) of the Securities
Exchange Act of 1934 that is incorporated by reference in the registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
</FONT></P>

<HR noshade align="center" width="100%" size=4>



<p style='page-break-before:always'></p><PAGE>
<P align="center">
<B><FONT size=2 face="serif">SIGNATURES</FONT></B></P>
<P align="left">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and
has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Montreal, Quebec, Canada on November 19, 2007. </FONT></P>
<P align="center">
<FONT size=2 face="serif">VISUALMED CLINICAL SOLUTIONS CORP.</FONT></P>
<P align="left" style="margin-left:450px">
<FONT size=2 face="serif">By: /s/Gerard Dab </FONT><BR>
<FONT size=2 face="serif">Gerard Dab, </FONT><BR>
<FONT size=2 face="serif">Principal Executive Officer</FONT></P>
<P align="left">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated. </FONT></P>
<TABLE border=0 width=100% cellspacing=0 cellpadding=0>
<TR>
     <TD width=30%></TD>
     <TD width=2%></TD>
     <TD width=49%></TD>
     <TD width=2%></TD>
     <TD width=16%></TD></TR>
<TR valign="bottom">
	<TD align=left nowrap>
<B><FONT size=1 face="serif">Signature</FONT></B>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>
<B><FONT size=1 face="serif">Title</FONT></B>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>
<B><FONT size=1 face="serif">Date</FONT></B>
	</TD>
</TR>
<TR>
	<TD colspan=5>&nbsp;

	</TD>
</TR>
<TR valign="bottom">
	<TD align=left nowrap>&nbsp;

	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>
<FONT size=2 face="serif">Principle Executive Officer, Secretary</FONT>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>
<FONT size=2 face="serif">November 19,</FONT>
	</TD>
</TR>
<TR valign="bottom">
	<TD align=left nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">/s/ Gerard Dab</FONT>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>
<FONT size=2 face="serif">and a member of the Board of Directors</FONT>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>
<FONT size=2 face="serif">2007</FONT>
	</TD>
</TR>
<TR valign="bottom">
	<TD align=left nowrap>
<FONT size=2 face="serif">Gerard Dab</FONT>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>&nbsp;

	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>&nbsp;

	</TD>
</TR>
<TR>
	<TD colspan=5>&nbsp;

	</TD>
</TR>
<TR valign="bottom">
	<TD align=left nowrap>&nbsp;

	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>
<FONT size=2 face="serif">President, Chief Science Officer and a</FONT>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>
<FONT size=2 face="serif">November 19,</FONT>
	</TD>
</TR>
<TR valign="bottom">
	<TD align=left nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">/s/ Arthur Gelston MD</FONT>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>
<FONT size=2 face="serif">member of the Board of Directors</FONT>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>
<FONT size=2 face="serif">2007</FONT>
	</TD>
</TR>
<TR valign="bottom">
	<TD align=left nowrap>
<FONT size=2 face="serif">Arthur Gelston MD</FONT>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>&nbsp;

	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>&nbsp;

	</TD>
</TR>
<TR>
	<TD colspan=5>&nbsp;

	</TD>
</TR>
<TR>
	<TD colspan=5>&nbsp;

	</TD>
</TR>
<TR valign="bottom">
	<TD align=left nowrap>&nbsp;

	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>
<FONT size=2 face="serif">Chief Operating Officer</FONT>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>
<FONT size=2 face="serif">November 19,</FONT>
	</TD>
</TR>
<TR valign="bottom">
	<TD align=left nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">/s/ Barry Scharf</FONT>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>&nbsp;

	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>
<FONT size=2 face="serif">2007</FONT>
	</TD>
</TR>
<TR>
	<TD colspan=5>&nbsp;

	</TD>
</TR>
<TR>
	<TD colspan=5>&nbsp;

	</TD>
</TR>
<TR valign="bottom">
	<TD align=left nowrap>&nbsp;

	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>
<FONT size=2 face="serif">Vice-President Finance</FONT>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>
<FONT size=2 face="serif">November 19,</FONT>
	</TD>
</TR>
<TR valign="bottom">
	<TD align=left nowrap>
<FONT size=2 face="serif">/s/ Jayne Kirby</FONT>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>&nbsp;

	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>
<FONT size=2 face="serif">2007</FONT>
	</TD>
</TR>
<TR valign="bottom">
	<TD align=left nowrap>
<FONT size=2 face="serif">Jayne Kirby</FONT>
	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>&nbsp;

	</TD>
	<TD>&nbsp;
	</TD>
	<TD align=left nowrap>&nbsp;

	</TD>
</TR>
</TABLE><BR>

<HR noshade align="center" width="100%" size=4>




</BODY>

</HTML>
[{"type": "S-8", "sequence": "1", "filename": "c51348_s-8.htm", "secsgml_size_bytes": 28279}]
{"company-data": {"conformed-name": "VisualMED Clinical Solutions Corp.", "cik": "0001102942", "assigned-sic": "7373", "irs-number": "880436055", "state-of-incorporation": "NV", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-147535", "film-number": "071259413"}, "business-address": {"street1": "1035 LAURIER STREET WEST", "city": "MONTREAL", "state": "A8", "zip": "H2V 2L1", "phone": "(514) 274-1115"}, "mail-address": {"street1": "1035 LAURIER STREET WEST", "city": "MONTREAL", "state": "A8", "zip": "H2V 2L1"}, "former-company": [{"former-conformed-name": "VisualMED Clinical Systems Corp.", "date-changed": "20050106"}, {"former-conformed-name": "ANCONA MINING CORP", "date-changed": "20000111"}]}
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
Registration Statement
Under
The Securities Act of 1933, as amended.
VISUALMED CLINICAL SOLUTIONS CORP.
(Exact name of registrant as specified in charter.)
Nevada
88-0436055
(State or other jurisdiction or organization)
(I.R.S. Employer Identification Number)
VISUALMED CLINICAL SOLUTIONS CORP.
1035 Laurier W. Suite 200
Montreal, Quebec
Canada H2V 2L1
(514) 274-1115
(Address and telephone of executive offices, including zip code.)
THE VISUALMED CLINICAL SOLUTIONS CORP.
NOVEMBER 2007 NONQUALIFIED STOCK OPTION PLAN
Gerard Dab, Chairman & CEO
VISUALMED CLINICAL SOLUTIONS CORP.
1035 Laurier W. Suite 200
Montreal, Quebec
Canada H2V 2L1
(514) 274-1115
(Name, address and telephone of agent for service)
Copies of all communications, including all communications sent to the agent for service, should be sent to:
Lombardo Dufresne LLP
350 Theodore Fremd Ave.
Rye, NY 10580
Tel. (914) 612 7016
Fax (914) 612 7038
CALCULATION OF REGISTRATION FEE
Proposed
Title of Each Class of
Aggregate Proposed
Maximum
Amount of
Securities to be
Amount to be
Maximum Offering
Aggregate Offering
Registration
Registered
Registered
Price per Unit/Share
Price [1]
Fee
Common Shares, $0.00001 par value,
issuable upon exercise of stock options
by Grantees
1,900,000
$
0.30
[1]
$
570,000
$
57.34
Totals
1,900,000
$
0.30
$
570,000
$
57.34
[1] Estimated solely for the purpose of calculating the registration fee pursuant to paragraphs (c) and (h) of Rule 457 under the Securities Act, as amended, based upon the average of the closing bid and ask prices for
    common shares, as quoted by the OTC Bulletin Board on November 13, 2007.
In addition, pursuant to rule 416(c) under the Securities Act of 1933 (the "Act"), this registration statement also covers an indeterminate amount of interests to be offered or sold pursuant to the employee
benefit plan described herein.
PART I.      INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS.
ITEM 1.      PLAN INFORMATION
See Item 2 below.
ITEM 2.      REGISTRANT INFORMATION AND EMPLOYEE PLAN ANNUAL INFORMATION.
The document containing the information specified in Part I of this registration statement on Form S-8 will be sent or given to participants in the Plan as specified by Rule 428(b)(1) under the Act, as amended. Such
documents are not required to be, and are not being, filed by the Registrant with the Securities and Exchange Commission, either as part of this registration statement or as prospectuses or prospectus supplements pursuant to Rule 424 under the Act,
as amended. Such documents, together with the documents incorporated by reference herein pursuant to Item 3 of Part II of this registration statement on Form S-8, constitute a prospectus that meets the requirements of Section 10(a) of the Act, as
amended.
The documents incorporated by reference in Item 3 of Part II of this registration statement are incorporated by reference in the Section 10(a) prospectus, and are available without charge, upon written or oral request to
VisualMED Clinical Solutions Corp., 1035 Laurier W., Suite 200, Montreal, Quebec Canada, H2V 2L1, (514) 274-1115, Attention: Corporate Secretary.
PART II.    INFORMATION REQUIRED
IN THE REGISTRATION STATEMENT.
ITEM
3.      INCORPORATION OF DOCUMENTS BY REFERENCE.
The Registrant hereby incorporates by reference into this Registration Statement the documents listed below. In addition, all documents subsequently filed pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities
Exchange Act of 1934 (the "Exchange Act"), prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by
reference into this Registration Statement and to be a part hereof from the date of filing of such documents:
(a) The Registrant's Annual Report on Form 10-KSB
    for the fiscal year ended June 30, 2007; and
(b) All other reports filed pursuant
    to section 13(a) or 15(d) of the Securities Exchange Act of 1934, since the
    end of the fiscal year covered by the Registrant's document referred to
    in (a) above.
ITEM 4.      DESCRIPTION OF SECURITIES.
Common Stock
Our authorized capital stock consists of 100,000,000 shares of common stock, $0.00001 par value per share. The holders of our common stock:
have equal ratable rights to dividends from funds legally available if and when declared by our
board of directors;
are entitled to share ratably in all of our assets available for distribution to holders of common
stock upon liquidation, dissolution or winding up of our affairs;
do not have preemptive, subscription or conversion rights and there are no redemption or sinking
fund provisions or rights; and
are entitled to one non-cumulative vote per share on all matters on which stockholders may vote.
As of November 13, 2007, we had 55,498,345 shares of common stock outstanding.
Non-cumulative voting
Holders of shares of our common stock do not have cumulative voting rights, which means that the holders of more than 50% of the outstanding shares, voting for the election of directors, can
elect all of the directors to be elected, if they so choose, and, in that event, the holders of the remaining shares will not be able to elect any of our directors.
Cash dividends
We have not declared any cash dividends in the last two fiscal years. We intend to retain future earnings for use in our business and do not anticipate declaring or paying any cash or stock
dividends on shares of our common shares in the near future. In addition, any determination to declare and pay dividends will be made by our Board of Directors in light of our earnings, financial position, capital requirements and other factors that
our Board of Directors deems relevant.
Warrants
As of November 19, 2007, there are 10,000,000 warrants outstanding to purchase common stock at an exercise price of $0.01 per share. The warrants are immediately exercisable and these
warrants are exercisable for a period of five years after the date of issuance, March 30, 2007, after which they will expire if not exercised.
Anti-takeover provisions
There are no Nevada anti-takeover provisions that may have the effect of delaying or preventing a change in control.
Stock transfer agent
Our stock transfer agent for our securities is Olde Monmouth Stock Transfer Co., Inc., 200 Memorial Parkway, Atlantic Highlands, NJ 07716 and its telephone number is (732) 872-2727.
ITEM 5. INTEREST OF NAMED EXPERTS AND COUNSEL.
Not Applicable.
ITEM 6. INDEMNIFICATION OF DIRECTORS AND OFFICERS.
Under our articles of incorporation and bylaws, we may indemnify an officer or director who is made a party to any proceeding, including a lawsuit, because of his position, if he acted in good
faith and in a manner he reasonably believed to be in our best interest. We may advance expenses incurred in defending a proceeding. To the extent that the officer or director is successful on the merits in a proceeding as to which he is to be
indemnified, we must indemnify him against all expenses incurred, including attorney's fees. With respect to a derivative action, indemnity may be made only for expenses actually and reasonably incurred in defending the proceeding, and if the
officer or director is judged liable, only by a court order. The indemnification is intended to be to the fullest extent permitted by the laws of the State of Nevada.
Insofar as indemnification for liabilities arising under the Act may be permitted to directors, officers and controlling persons of the small business issuer pursuant to the foregoing
provisions, or otherwise, the small business issuer has been advised that in the opinion of the Securities Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable.
Regarding indemnification for liabilities arising under the Act, which may be permitted to directors or officers under Nevada law, we are informed that, in the opinion of the Securities and
Exchange Commission, indemnification is against public policy, as expressed in the Act and is, therefore, unenforceable.
ITEM 7.      EXEMPTION FROM REGISTRATION.
Not Applicable.
ITEM 8.      EXHIBITS.
Exhibit 4.1
VisualMED Clinical Solutions Corp. November 2007 Nonqualified Stock Option Plan
Exhibit 4.2
Form of Non-Qualified Stock Option Agreement
Exhibit 5.1
Opinion of Lombardo Dufresne LLP., Attorneys at Law
Exhibit 23.1
Consent of Lombardo Dufresne LLP, (included in Exhibit 5.1)
Exhibit 23.2
Consent of Manning Elliott LLP, Independent Registered Public Accounting Firm
ITEM 9. UNDERTAKINGS.
The undersigned registrant hereby undertakes:
1. To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement; 2. To include any material information with respect to the plan of distribution not
previously disclosed in the registration statement or any material change to such information in the registration statement;
3. That, for the purpose of determining any liability under the Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial bona fide offering thereof; and 4. To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the
offering.
The undersigned registrant hereby undertakes that, for the purposes of determining any liability under the Act, each filing of the Registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Securities
Exchange Act of 1934 that is incorporated by reference in the registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and
has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Montreal, Quebec, Canada on November 19, 2007.
VISUALMED CLINICAL SOLUTIONS CORP.
By: /s/Gerard Dab
Gerard Dab,
Principal Executive Officer
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.
Signature
Title
Date
Principle Executive Officer, Secretary
November 19,
/s/ Gerard Dab
and a member of the Board of Directors
2007
Gerard Dab
President, Chief Science Officer and a
November 19,
/s/ Arthur Gelston MD
member of the Board of Directors
2007
Arthur Gelston MD
Chief Operating Officer
November 19,
/s/ Barry Scharf
2007
Vice-President Finance
November 19,
/s/ Jayne Kirby
2007
Jayne Kirby